SEQENS competitors and similar companiesClear all

SEQENS's competitors and similar companies include Sartorius Stedim Biotech, Dottikon and Cytiva.
SEQENS
SEQENS
SEQENS (previously known as Novacap) is a company specializing in pharmaceutical synthesis and specialty ingredients.
Sartorius Stedim Biotech
Sartorius Stedim Biotech
Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.
Dottikon
Dottikon
Dottikon is a company that manufactures active pharmaceutical ingredients (APIs), intermediates, and performance chemicals.
Cytiva
Cytiva
Cytiva (formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics.
Founding Date
Founding Date
2003
Founding Date
2007
Founding Date
1913
Founding Date
1968
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Écully, FR HQ
Saint Jean Sur Richelieu, CA
Taizhou Shi, CN
Zhenjiang, CN
Turku, FI
Bourgoin Jallieu, FR
see more
Locations
Aubagne, FR HQ
Jaipur, IN
Bohemia, US
Locations
Dottikon, CH HQ
Chicago, US
Locations
Marlborough, US HQ
Macquarie Park, AU
Parramatta, AU
Wagram, AT
Wien, AT
Hoegaarden, BE
São Paulo, BR
see more
Employees
Employees
3,200903% increase
Employees
8,74616% increase
Employees
670
Employees
10,00025% increase
Twitter followers
Twitter followers
533
Twitter followers
N/A
Twitter followers
1
Twitter followers
15.7 k
Alexa Website Rank
Alexa Website Rank
398019
Alexa Website Rank
N/A
Alexa Website Rank
604711
Alexa Website Rank
255475
Employee Rating
Employee Rating
3.3
Employee Rating
3.9
Employee Rating
3
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€2.9b (FY, 2021)
Revenue (est.)
CHF251.9m (FY, 2022)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
€1.3b (FY, 2021)
Cost of goods
CHF53.3m (FY, 2022)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€1.6b (FY, 2021)
Gross profit
CHF201.5m (FY, 2022)
Gross profit
N/A
Net income
Net income
N/A
Net income
€414.3m (FY, 2021)
Net income
CHF59.3m (FY, 2022)
Net income
N/A
For sources of this data, please see the company profile

View company profiles

Sartorius Stedim Biotech
HQ
Aubagne, FR
Employees
8,746↑ 16% increase

Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.

View company
Dottikon
HQ
Dottikon, CH
Employees
670

Dottikon is a company that manufactures active pharmaceutical ingredients (APIs), intermediates, and performance chemicals.

View company
Cytiva
HQ
Marlborough, US

Cytiva (formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics.

View company